1. Home
  2. INSM vs HRL Comparison

INSM vs HRL Comparison

Compare INSM & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • HRL
  • Stock Information
  • Founded
  • INSM 1988
  • HRL 1891
  • Country
  • INSM United States
  • HRL United States
  • Employees
  • INSM N/A
  • HRL N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • HRL Meat/Poultry/Fish
  • Sector
  • INSM Health Care
  • HRL Consumer Staples
  • Exchange
  • INSM Nasdaq
  • HRL Nasdaq
  • Market Cap
  • INSM 17.3B
  • HRL 16.6B
  • IPO Year
  • INSM 2000
  • HRL N/A
  • Fundamental
  • Price
  • INSM $98.24
  • HRL $30.80
  • Analyst Decision
  • INSM Strong Buy
  • HRL Buy
  • Analyst Count
  • INSM 17
  • HRL 3
  • Target Price
  • INSM $106.80
  • HRL $34.00
  • AVG Volume (30 Days)
  • INSM 6.2M
  • HRL 2.9M
  • Earning Date
  • INSM 08-07-2025
  • HRL 05-29-2025
  • Dividend Yield
  • INSM N/A
  • HRL 3.77%
  • EPS Growth
  • INSM N/A
  • HRL N/A
  • EPS
  • INSM N/A
  • HRL 1.36
  • Revenue
  • INSM $381,030,000.00
  • HRL $11,924,157,000.00
  • Revenue This Year
  • INSM $28.03
  • HRL $2.57
  • Revenue Next Year
  • INSM $120.54
  • HRL $2.63
  • P/E Ratio
  • INSM N/A
  • HRL $22.59
  • Revenue Growth
  • INSM 20.77
  • HRL N/A
  • 52 Week Low
  • INSM $60.40
  • HRL $27.59
  • 52 Week High
  • INSM $106.83
  • HRL $33.80
  • Technical
  • Relative Strength Index (RSI)
  • INSM 62.07
  • HRL 55.33
  • Support Level
  • INSM $98.85
  • HRL $29.97
  • Resistance Level
  • INSM $106.83
  • HRL $31.11
  • Average True Range (ATR)
  • INSM 3.17
  • HRL 0.49
  • MACD
  • INSM -0.86
  • HRL -0.01
  • Stochastic Oscillator
  • INSM 20.61
  • HRL 73.97

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and become a branded food company. The firm sells its wares through multiple channels, including US retail (62% of fiscal 2024 sales), US food service (32%), and international (6%). By product, 72% of fiscal 2024 sales were from perishable food and 28% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

Share on Social Networks: